Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that the United States Patent and Trademark Office has granted U.S. Patent Number 9,707,333 (the ‘333 Patent), entitled “EXTRACORPOREAL REMOVAL ...
Read More »Exosome Patent Granted – Detection of analytes present in exosomes
United States Patent 9,354,225 Lizano-Gonzalez , et al. May 31, 2016 Detection of analytes present in exosomes AbstractThe invention provides methods for detection in stored biological samples of PrPsc and other analytes that are present in exosomes. Inventors: Lizano-Gonzalez; ...
Read More »New Patent Application Published – Sample analysis device and capturing method for exosomes
Itonaga, Makoto (Yokohama-shi, JP) Yagyu, Shingo (Yokohama-shi, JP) Hasegawa, Yuichi (Yokohama-shi, JP) Tsujita, Koji (Yokohama-shi, JP) Ono, Masayuki (Yokohama-shi, JP) Abstract A recessed portion and a protruding portion arranged periodically are formed on a base portion. In the recessed portion, ...
Read More »New Patent Published – miRNA biogenesis in exosomes for diagnosis and therapy
Kalluri, Raghu (Houston, TX, US) Melo, Sónia (Porto, PT) Abstract The presently disclosed subject matter provides methods of diagnosis of cancer or adverse pregnancy outcomes in a subject by measuring amounts of one or more microRNAs present in cancer-derived exosomes ...
Read More »